CD8A and neoplasm: The increased presence of PD-1hi TOX+ TCF-1− CD8 T cells in tumor biopsies correlates with a poorer prognosis in patients treated with ICT and these cells likely lack the ability to gain significant effector function following PD-1/PD-L1 blockade32,33.